Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.14
-0.42 (-7.55%)
At close: Oct 2, 2026, 4:00 PM EDT
5.16
+0.02 (0.39%)
After-hours: Oct 2, 2026, 7:57 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.8 billion as of October 2, 2026. Its market cap has increased by 42.51% in one year.
Market Cap
1.80B
Enterprise Value
1.56B
1-Year Change
42.51%
Ranking
Category
Stock Price
$5.14
ChartMarket Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.80B, an increase of 934.38%. That is a compound annual growth rate of 46.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.80B | -41.25% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.89B |
| Lakefront Biotherapeutics NV | 1.88B |
| Sarepta Therapeutics | 1.85B |
| Xencor | 1.85B |
| Zenas BioPharma | 1.84B |
| Mesoblast | 1.84B |
| Zymeworks | 1.78B |
| Septerna | 1.76B |